REMSleep Holdings, Inc. (RMSL)
OTCMKTS · Delayed Price · Currency is USD
0.0052
-0.0013 (-19.75%)
At close: Jan 20, 2026
REMSleep Holdings Revenue
REMSleep Holdings had revenue of $7.45K in the quarter ending September 30, 2025, a decrease of -79.99%. This brings the company's revenue in the last twelve months to $6.73K, down -94.83% year-over-year. In the year 2024, REMSleep Holdings had annual revenue of $117.19K, down -42.48%.
Revenue (ttm)
6.73K
Revenue Growth
-94.83%
P/S Ratio
1,617.15
Revenue / Employee
3.36K
Employees
2
Market Cap
10.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.19K | -86.53K | -42.48% |
| Dec 31, 2023 | 203.72K | -117.00K | -36.48% |
| Dec 31, 2022 | 320.72K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
REMSleep Holdings News
- 3 months ago - Deltawave(TM) Launch Plan - Accesswire
- 6 months ago - Deltawave Marketing Plan - Accesswire
- 7 months ago - Deltawave CPAP Mask - Accesswire
- 9 months ago - REMSleep Enters Formal Agreement with Major Distributor - Accesswire
- 1 year ago - REMSleep Holdings, Inc. Shareholder Update - GlobeNewsWire
- 1 year ago - REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office - GlobeNewsWire
- 2 years ago - REMSleep Holdings Patent Status - GlobeNewsWire
- 2 years ago - REMSleep Holdings Shareholder Update - GlobeNewsWire